Caves and Lakes KY

Experimental Alzheimer's Drug May Slow Decline, But Safety Concerns Linger

Franklin Favorite

Nov 30, 2022

WEDNESDAY, Nov. 30, 2022 (HealthDay News) -- The experimental Alzheimer's drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new…

Read the full story at Franklin Favorite

Experimental Alzheimer's Drug May Slow Decline, But Safety Concerns Linger

More from Caves and Lakes

Kentucky freight train carrying molten sulfur derails, leaks hazardous chemical in Todd County

Kentucky teacher accused of exposing herself to student during shower video chat to arrange sex

Man charged in Simpson hit-and-run fatality

Belarus opposition figure returned to prison after surgery

Ketolicious Kitchens Launches Keto Mexican Comfort Food Product Line

'Torso Killer' admits killing 5 women decades ago near NYC

USS Arizona survivor: Honor those killed at Pearl Harbor

Memphis hospital: Halt to trans procedures is temporary